{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:58:07Z","timestamp":1780876687076,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>Cholecystectomy is one of the most common surgeries worldwide, yet its association with colorectal cancer (CRC) risk remains controversial. Recent advances have linked gut microbiota and bile acid alterations to this risk. This review synthesizes epidemiological evidence and molecular mechanisms, focusing on the microbiota-bile acid-FXR signaling axis, and proposes a personalized prevention framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary of contents<\/jats:title>\n                    <jats:p>Epidemiological data reveal consistent patterns: proximal colon cancer predominance, higher risk in women, and peak incidence 5\u201315 years post-surgery. Cholecystectomy induces gut microbiota dysbiosis (decreased Bifidobacterium breve, increased Ruminococcus gnavus) and bile acid disturbances (elevated TUDCA\/GUDCA, altered protective bile acids), which converge on FXR signaling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Core findings<\/jats:title>\n                    <jats:p>The FXR signaling axis is a central hub. Yang et al. (Nat Commun 2025) showed that cholecystectomy-induced microbiota shifts alter bile acids, suppress FXR, disrupt FXR\/\u03b2-catenin interaction, and promote tumorigenesis. The FXR agonist obeticholic acid prevents these effects preclinically, but systemic toxicity limits clinical use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and significance<\/jats:title>\n                    <jats:p>We propose personalized risk stratification integrating demographics, microbial signatures, and metabolic biomarkers. Interventions include gut-restricted FXR agonists, probiotics, and Mediterranean diet. Future directions include prospective validation and dynamic network modeling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43046-026-00360-z","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:01:48Z","timestamp":1780873308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cholecystectomy-associated gut microbiota dysbiosis promotes colorectal carcinogenesis: from epidemiological controversy to FXR-centered mechanistic insights"],"prefix":"10.1186","volume":"38","author":[{"given":"Zhongqin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"7","key":"360_CR1","doi-asserted-by":"publisher","first-page":"e079599","DOI":"10.1136\/bmjopen-2023-079599","volume":"14","author":"E Harrison","year":"2024","unstructured":"Harrison E, Kathir Kamarajah S, NIHR Global Health Research Unit on Global Surgery. Global evaluation and outcomes of cholecystectomy: protocol for a multicentre, international, prospective cohort study (GlobalSurg 4). BMJ Open. 2024;14(7):e079599. https:\/\/doi.org\/10.1136\/bmjopen-2023-079599. PMID: 39059804; PMCID: PMC11287069.","journal-title":"BMJ Open"},{"key":"360_CR2","doi-asserted-by":"publisher","unstructured":"Konings B, Balsiger LM, Hreinsson JP, Simr\u00e9n M, Bangdiwala SI, Sperber AD, Palsson OS, T\u00f6rnblom H, Tack J. Global prevalence and gastrointestinal symptom burden of individuals with a history of cholecystectomy. Gut. 2025;75(1):65\u201371. https:\/\/doi.org\/10.1136\/gutjnl-2024-334531. PMID: 40803749.","DOI":"10.1136\/gutjnl-2024-334531"},{"issue":"6","key":"360_CR3","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/ijc.34607","volume":"153","author":"F Boekstegers","year":"2023","unstructured":"Boekstegers F, Scherer D, Barahona Ponce C, Marcelain K, G\u00e1rate-Calder\u00f3n V, Waldenberger M, Morales E, Rojas A, Munoz C, Retamales J, de Toro G, Barajas O, Rivera MT, Cort\u00e9s A, Loader D, Saavedra J, Guti\u00e9rrez L, Ortega A, Bertr\u00e1n ME, Bartolotti L, Gabler F, Campos M, Alvarado J, Mois\u00e1n F, Spencer L, Nervi B, Carvajal-Hausdorf D, Losada H, Almau M, Fern\u00e1ndez P, Olloquequi J, Fuentes-Guajardo M, Gonzalez-Jose R, Bortolini MC, Acu\u00f1a-Alonzo V, Gallo C, Linares AR, Rothhammer F, Lorenzo Bermejo J. Development and internal validation of a multifactorial risk prediction model for gallbladder cancer in a high-incidence country. Int J Cancer. 2023;153(6):1151\u201361. https:\/\/doi.org\/10.1002\/ijc.34607. Epub 2023 Jun 1. PMID: 37260300.","journal-title":"Int J Cancer"},{"issue":"2","key":"360_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.14701\/ahbps.24-198","volume":"29","author":"JI Park","year":"2025","unstructured":"Park JI, Chung YK, Lee YM, Nam CW, Nah YW. Comparative analysis of postoperative outcomes of single-incision cholecystectomy: Propensity score matching of robotic surgery using the da Vinci SP system and da Vinci Xi system vs. laparoscopic surgery. Ann Hepatobiliary Pancreat Surg. 2025;29(2):140\u20139. https:\/\/doi.org\/10.14701\/ahbps.24-198. Epub 2025 Jan 20. PMID: 39827900; PMCID: PMC12093242.","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"issue":"3","key":"360_CR5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/cancers14030658","volume":"14","author":"D M\u00fchl","year":"2022","unstructured":"M\u00fchl D, Herold M, Herold Z, Horny\u00e1k L, Szasz AM, Dank M. Longitudinal Analysis of 1\u03b1,25-dihidroxyvitamin D3 and Homocysteine Changes in Colorectal Cancer. Cancers (Basel). 2022;14(3):658. https:\/\/doi.org\/10.3390\/cancers14030658. PMID: 35158926; PMCID: PMC8833406.","journal-title":"Cancers (Basel)"},{"issue":"24","key":"360_CR6","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3390\/cells14242006","volume":"14","author":"H Salameh","year":"2025","unstructured":"Salameh H, Naseem N, Chattha MA, Ramesh J, Ramy H, Cizkova D, Kubatka P, B\u00fcsselberg D. Oncolytic Virotherapy in Colorectal Cancer: Mechanistic Insights, Enhancer Strategies, and Translational Combinations. Cells. 2025;14(24):2006. https:\/\/doi.org\/10.3390\/cells14242006. PMID: 41440025; PMCID: PMC12732131.","journal-title":"Cells"},{"issue":"3","key":"360_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11538-026-01594-7","volume":"88","author":"G Hawi","year":"2026","unstructured":"Hawi G, Kim PS, Lee PP. Modelling Immune Dynamics in Locally Advanced MSI-H\/dMMR Colorectal Cancer with Neoadjuvant Pembrolizumab Treatment: From Differential Equations to an Agent-Based Framework. Bull Math Biol. 2026;88(3):35. https:\/\/doi.org\/10.1007\/s11538-026-01594-7. PMID: 41627569; PMCID: PMC12864367.","journal-title":"Bull Math Biol"},{"issue":"11","key":"360_CR8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/cac2.70059","volume":"45","author":"Y Hu","year":"2025","unstructured":"Hu Y, Kharazmi E, Liang Q, Brenner H, Sundquist J, Sundquist K, Fallah M. Risk of colorectal cancer by family history of both colorectal carcinomas and colorectal polyps: a nationwide cohort study. Cancer Commun (Lond). 2025;45(11):1407\u201316. Epub 2025 Sep 2. PMID: 40898381; PMCID: PMC12629855.","journal-title":"Cancer Commun (Lond)"},{"issue":"6","key":"360_CR9","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3390\/medicina60060898","volume":"60","author":"IS Coman","year":"2024","unstructured":"Coman IS, Vital RC, Coman VE, Burleanu C, Li\u0163escu M, Florea CG, Cristian DA, Gorecki GP, Radu PA, Ple\u015fea IE, Erchid A, Grigorean VT. Emergency and Elective Colorectal Cancer-Relationship between Clinical Factors, Tumor Topography and Surgical Strategies: A Cohort Study. Med (Kaunas). 2024;60(6):898. https:\/\/doi.org\/10.3390\/medicina60060898. PMID: 38929515; PMCID: PMC11205460.","journal-title":"Med (Kaunas)"},{"key":"360_CR10","doi-asserted-by":"publisher","first-page":"710165","DOI":"10.3389\/fcell.2021.710165","volume":"9","author":"S Wang","year":"2021","unstructured":"Wang S, Liu Y, Li J, Zhao L, Yan W, Lin B, Guo X, Wei Y. Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality. Front Cell Dev Biol. 2021;9:710165. PMID: 34490259; PMCID: PMC8417943.","journal-title":"Front Cell Dev Biol"},{"key":"360_CR11","doi-asserted-by":"publisher","unstructured":"Vernick LJ, Kuller LH, Lohsoonthorn P, Rycheck RR, Redmond CK. Relationship between cholecystectomy and ascending colon cancer. Cancer. 1980;45(2):392-5. https:\/\/doi.org\/10.1002\/1097-0142(19800115)45:2%3C392::aid-cncr2820450234%3E3.0.co;2-9. PMID: 7351021.","DOI":"10.1002\/1097-0142(19800115)45:2%3C392::aid-cncr2820450234%3E3.0.co;2-9"},{"issue":"19","key":"360_CR12","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.3390\/cancers17193114","volume":"17","author":"PH Nelis","year":"2025","unstructured":"Nelis PH, Grotto S, Ibis KA, Nahar N, Belhaj A, Benhadda M, Vanlander A, Messaoudi N. Colorectal Cancer Risk Following Cholecystectomy: An Updated Systematic Review. Cancers (Basel). 2025;17(19):3114. https:\/\/doi.org\/10.3390\/cancers17193114. PMID: 41097643; PMCID: PMC12523835.","journal-title":"Cancers (Basel)"},{"key":"360_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.wneu.2020.01.166","volume":"137","author":"J Zhang","year":"2020","unstructured":"Zhang J, Li ZH, Wang JF, Chen YH, Wang N, Wang Y. Prognostic Value of Abnormal Muscle Response During Microvascular Decompression for Hemifacial Spasm: A Meta-Analysis. World Neurosurg. 2020;137:8\u201317. Epub 2020 Feb 14. PMID: 32006731.","journal-title":"World Neurosurg"},{"issue":"6","key":"360_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3961\/jpmph.18.105","volume":"51","author":"J Lee","year":"2018","unstructured":"Lee J, Choe S, Park JW, Jeong SY, Shin A. The Risk of Colorectal Cancer After Cholecystectomy or Appendectomy: A Population-based Cohort Study in Korea. J Prev Med Public Health. 2018;51(6):281\u20138. https:\/\/doi.org\/10.3961\/jpmph.18.105. Epub 2018 Oct 29. PMID: 30514058; PMCID: PMC6283741.","journal-title":"J Prev Med Public Health"},{"key":"360_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jss.2024.10.018","volume":"304","author":"RA Mu\u00f1oz","year":"2024","unstructured":"Mu\u00f1oz RA, Ramos AA, Miranda FJ, De La Rosa JE, Mu\u00f1oz AE, Ram\u00edrez AA, Chavez EP, Gallardo G, Pizarro S. Cholecystectomy Is a Risk Factor for Proximal Colon Cancer That May Also Relate to its Aggressiveness. J Surg Res. 2024;304:152\u201361. Epub 2024 Nov 15. PMID: 39547064.","journal-title":"J Surg Res"},{"issue":"11","key":"360_CR16","doi-asserted-by":"publisher","first-page":"7954","DOI":"10.21037\/tcr-2025-1493","volume":"14","author":"S Zhou","year":"2025","unstructured":"Zhou S, Zhao B, Qu J, Gao X, Wang X, Yang C, Tong Q, Zheng L. Association between cholecystectomy and colorectal cancer: results from the National Health and Nutrition Examination Survey (NHANES) 2017\u20132023 and Mendelian randomization analyses. Transl Cancer Res. 2025;14(11):7954\u201366. https:\/\/doi.org\/10.21037\/tcr-2025-1493. Epub 2025 Nov 26. PMID: 41378025; PMCID: PMC12686136.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"360_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11684-024-1111-5","volume":"19","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Shen L, Huo Y, Wan Q, Qin Y, Hu R, Shi L, Su Q, Yu X, Yan L, Qin G, Tang X, Chen G, Xu Y, Wang T, Zhao Z, Gao Z, Wang G, Shen F, Gu X, Luo Z, Chen L, Li Q, Ye Z, Zhang Y, Liu C, Wang Y, Wu S, Yang T, Deng H, Chen L, Zeng T, Zhao J, Mu Y, Wang W, Ning G, Lu J, Xu M, Bi Y, Hu W. Gallstones, cholecystectomy, and cancer risk: an observational and Mendelian randomization study. Front Med. 2025;19(1):79\u201389. https:\/\/doi.org\/10.1007\/s11684-024-1111-5. Epub 2024 Dec 26. PMID: 39722067.","journal-title":"Front Med"},{"key":"360_CR18","doi-asserted-by":"publisher","unstructured":"Lorestani P, Faghihkhorasani F, Saffar H, Darabi B, Tavakoli Y, Lorestani AM, Ghiasi M, Jazi K. The Impact of Cholecystectomy on Colorectal Cancer Risk: A Comprehensive Review on Risk Factors and the Association. Curr Gastroenterol Rep. 2025;27(1):59. https:\/\/doi.org\/10.1007\/s11894-025-01008-z. PMID: 40784992.","DOI":"10.1007\/s11894-025-01008-z"},{"key":"360_CR19","doi-asserted-by":"publisher","unstructured":"Shen Y, Fan N, Ma SX, Cheng X, Yang X, Wang G. Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy. MedComm (2020). 2025;6(5):e70168. https:\/\/doi.org\/10.1002\/mco2.70168. PMID: 40255918; PMCID: PMC12006732.","DOI":"10.1002\/mco2.70168"},{"issue":"8","key":"360_CR20","doi-asserted-by":"publisher","first-page":"e0181852","DOI":"10.1371\/journal.pone.0181852","volume":"12","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Liu H, Li L, Ai M, Gong Z, He Y, Dong Y, Xu S, Wang J, Jin B, Liu J, Teng Z. Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies. PLoS One. 2017;12(8):e0181852. https:\/\/doi.org\/10.1371\/journal.pone.0181852. Erratum in: PLoS One. 2018 Jan 17;13(1):e0191587. doi: 10.1371\/journal.pone.0191587. PMID: 28771518; PMCID: PMC5542607.","journal-title":"PLoS One"},{"key":"360_CR21","doi-asserted-by":"publisher","unstructured":"Alley PG, Lee SP. The increased risk of proximal colonic cancer after cholecystectomy. Dis Colon Rectum. 1983;26(8):522-4. https:\/\/doi.org\/10.1007\/BF02563745. PMID: 6872779.","DOI":"10.1007\/BF02563745"},{"issue":"11","key":"360_CR22","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1097\/MEG.0000000000002827","volume":"36","author":"X Zhou","year":"2024","unstructured":"Zhou X, Xu L, Zhang Q, Chen W, Xie H. The impact of long-term (\u2265\u20095 years) cholecystectomy on gut microbiota changes and its influence on colorectal cancer risk: based on 16S rDNA sequencing analysis. Eur J Gastroenterol Hepatol. 2024;36(11):1288\u201397. Epub 2024 Jul 15. PMID: 39012652.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"360_CR23","doi-asserted-by":"publisher","first-page":"2168101","DOI":"10.1080\/19490976.2023.2168101","volume":"15","author":"Y Xu","year":"2023","unstructured":"Xu Y, Wang J, Wu X, Jing H, Zhang S, Hu Z, Rao L, Chang Q, Wang L, Zhang Z. Gut microbiota alteration after cholecystectomy contributes to post-cholecystectomy diarrhea via bile acids stimulating colonic serotonin. Gut Microbes. 2023;15(1):2168101. PMID: 36732497; PMCID: PMC9897804.","journal-title":"Gut Microbes"},{"issue":"20","key":"360_CR24","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.3390\/nu15204399","volume":"15","author":"F Xu","year":"2023","unstructured":"Xu F, Chen R, Zhang C, Wang H, Ding Z, Yu L, Tian F, Chen W, Zhou Y, Zhai Q. Cholecystectomy Significantly Alters Gut Microbiota Homeostasis and Metabolic Profiles: A Cross-Sectional Study. Nutrients. 2023;15(20):4399. https:\/\/doi.org\/10.3390\/nu15204399. PMID: 37892474; PMCID: PMC10609985.","journal-title":"Nutrients"},{"key":"360_CR25","doi-asserted-by":"publisher","first-page":"1000563","DOI":"10.3389\/fmed.2022.1000563","volume":"9","author":"X Jiang","year":"2022","unstructured":"Jiang X, Jiang Z, Cheng Q, Sun W, Jiang M, Sun Y. Cholecystectomy promotes the development of colorectal cancer by the alternation of bile acid metabolism and the gut microbiota. Front Med (Lausanne). 2022;9:1000563. PMID: 36213655; PMCID: PMC9540502.","journal-title":"Front Med (Lausanne)"},{"key":"360_CR26","doi-asserted-by":"publisher","unstructured":"Alberts DS, Mart\u00ednez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, Roe D, Lance P. Phoenix and Tucson Gastroenterologist Networks. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst. 2005;97(11):846\u2009\u2013\u200953. https:\/\/doi.org\/10.1093\/jnci\/dji144. PMID: 15928305.","DOI":"10.1093\/jnci\/dji144"},{"issue":"3","key":"360_CR27","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/jgh.14526","volume":"34","author":"YH Kim","year":"2019","unstructured":"Kim YH, Kim JH, Kim BG, Lee KL, Kim JW, Koh SJ. Tauroursodeoxycholic acid attenuates colitis-associated colon cancer by inhibiting nuclear factor kappaB signaling. J Gastroenterol Hepatol. 2019;34(3):544\u201351. https:\/\/doi.org\/10.1111\/jgh.14526. Epub 2018 Nov 14. PMID: 30378164.","journal-title":"J Gastroenterol Hepatol"},{"key":"360_CR28","doi-asserted-by":"publisher","unstructured":"Modica S, Murzilli S, Salvatore L, Schmidt DR, Moschetta A. Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res. 2008;68(23):9589-94. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1791. PMID: 19047134.","DOI":"10.1158\/0008-5472.CAN-08-1791"},{"issue":"8","key":"360_CR29","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41419-020-02819-w","volume":"11","author":"J Yu","year":"2020","unstructured":"Yu J, Li S, Guo J, Xu Z, Zheng J, Sun X. Farnesoid X receptor antagonizes Wnt\/\u03b2-catenin signaling in colorectal tumorigenesis. Cell Death Dis. 2020;11(8):640. https:\/\/doi.org\/10.1038\/s41419-020-02819-w. PMID: 32807788; PMCID: PMC7431544.","journal-title":"Cell Death Dis"},{"issue":"5","key":"360_CR30","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.cell.2019.01.036","volume":"176","author":"T Fu","year":"2019","unstructured":"Fu T, Coulter S, Yoshihara E, Oh TG, Fang S, Cayabyab F, Zhu Q, Zhang T, Leblanc M, Liu S, He M, Waizenegger W, Gasser E, Schnabl B, Atkins AR, Yu RT, Knight R, Liddle C, Downes M, Evans RM. FXR Regulates Intestinal Cancer Stem Cell Proliferation. Cell. 2019;176(5):1098\u2013e111218. https:\/\/doi.org\/10.1016\/j.cell.2019.01.036. PMID: 30794774; PMCID: PMC6701863.","journal-title":"Cell"},{"issue":"24","key":"360_CR31","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1158\/0008-5472.CAN-24-3898","volume":"85","author":"F Sun","year":"2025","unstructured":"Sun F, Wang K, Dong X, Secaira-Morocho H, Hui A, Cai C, Sze JJ, Low B, Udgata S, Pasch CA, Huan T, Deming DA, Zhu Q, Jiang J, Fu T. The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression. Cancer Res. 2025;85(24):4937\u201357. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-3898 PMID: 40960502; PMCID: PMC12871761.","journal-title":"Cancer Res"},{"issue":"7","key":"360_CR32","doi-asserted-by":"publisher","first-page":"e0028825","DOI":"10.1128\/msystems.00288-25","volume":"10","author":"Q Hao","year":"2025","unstructured":"Hao Q, Huang F, Chang L, Dai H, Chen W, Yao Y, Zhen Y. Weissella cibaria suppresses colitis-associated colorectal cancer by modulating the gut microbiota-bile acid-FXR axis. mSystems. 2025;10(7):e0028825. https:\/\/doi.org\/10.1128\/msystems.00288-25. Epub 2025 Jul 3. PMID: 40607831; PMCID: PMC12282153.","journal-title":"mSystems"},{"issue":"1","key":"360_CR33","doi-asserted-by":"publisher","first-page":"12502","DOI":"10.1038\/s41598-017-12629-4","volume":"7","author":"YM Attia","year":"2017","unstructured":"Attia YM, Tawfiq RA, Ali AA, Elmazar MM, The FXR, Agonist O, Acid, Suppresses HCC. Proliferation & Metastasis: Role of IL-6\/STAT3 Signalling Pathway. Sci Rep. 2017;7(1):12502. https:\/\/doi.org\/10.1038\/s41598-017-12629-4. PMID: 28970500; PMCID: PMC5624958.","journal-title":"Sci Rep"},{"issue":"24","key":"360_CR34","doi-asserted-by":"publisher","first-page":"14549","DOI":"10.1111\/jcmm.16083","volume":"24","author":"S Li","year":"2020","unstructured":"Li S, Xu Z, Guo J, Zheng J, Sun X, Yu J. Farnesoid X receptor activation induces antitumour activity in colorectal cancer by suppressing JAK2\/STAT3 signalling via transactivation of SOCS3 gene. J Cell Mol Med. 2020;24(24):14549\u201360. https:\/\/doi.org\/10.1111\/jcmm.16083. Epub 2020 Nov 9. PMID: 33164339; PMCID: PMC7754034.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"360_CR35","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1002\/hep.29569","volume":"67","author":"KV Kowdley","year":"2018","unstructured":"Kowdley KV, Luketic V, Chapman R, Hirschfield GM, Poupon R, Schramm C, Vincent C, Rust C, Par\u00e9s A, Mason A, Marschall HU, Shapiro D, Adorini L, Sciacca C, Beecher-Jones T, B\u00f6hm O, Pencek R, Jones D, Obeticholic Acid PBC Monotherapy Study Group. A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis. Hepatology. 2018;67(5):1890\u2013902. https:\/\/doi.org\/10.1002\/hep.29569. Epub 2018 Jan 29. PMID: 29023915; PMCID: PMC5947631.","journal-title":"Hepatology"},{"key":"360_CR36","doi-asserted-by":"publisher","unstructured":"So D, Whelan K, Rossi M, Morrison M, Holtmann G, Kelly JT, Shanahan ER, Staudacher HM, Campbell KL. Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am J Clin Nutr. 2018;107(6):965\u2013983. https:\/\/doi.org\/10.1093\/ajcn\/nqy041. PMID: 29757343.","DOI":"10.1093\/ajcn\/nqy041"},{"issue":"2","key":"360_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.15386\/mpr-2526","volume":"96","author":"TD Fratila","year":"2023","unstructured":"Fratila TD, Ismaiel A, Dumitrascu DL. Microbiome modulation in the prevention and management of colorectal cancer: a systematic review of clinical interventions. Med Pharm Rep. 2023;96(2):131\u201345. https:\/\/doi.org\/10.15386\/mpr-2526. Epub 2023 Apr 27. PMID: 37197270; PMCID: PMC10184528.","journal-title":"Med Pharm Rep"},{"issue":"1","key":"360_CR38","doi-asserted-by":"publisher","first-page":"2496408","DOI":"10.1080\/07853890.2025.2496408","volume":"57","author":"C Nam","year":"2025","unstructured":"Nam C, Lee JS, Kim JS, Lee TY, Yoon YC. Clinical perspectives on post-cholecystectomy syndrome: a narrative review. Ann Med. 2025;57(1):2496408. https:\/\/doi.org\/10.1080\/07853890.2025.2496408. Epub 2025 Apr 30. PMID: 40304725; PMCID: PMC12044903.","journal-title":"Ann Med"},{"issue":"6","key":"360_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41430-024-01426-8","volume":"78","author":"A McHugh","year":"2024","unstructured":"McHugh A, O\u2019Connell E, Gurd B, Rae P, George ES, Kleckner AS, Baguley BJ. Mediterranean-style dietary interventions in adults with cancer: a systematic review of the methodological approaches, feasibility, and preliminary efficacy. Eur J Clin Nutr. 2024;78(6):463\u201376. https:\/\/doi.org\/10.1038\/s41430-024-01426-8. Epub 2024 Mar 8. PMID: 38459161; PMCID: PMC11182747.","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"360_CR40","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.gassur.2024.02.007","volume":"28","author":"X Chi","year":"2024","unstructured":"Chi X, Li X, Wang F, Huang P, Liu J. Simultaneous cholecystectomy for asymptomatic gallstones during elective colorectal cancer surgery. J Gastrointest Surg. 2024;28(5):656\u201361. https:\/\/doi.org\/10.1016\/j.gassur.2024.02.007. Epub 2024 Feb 9. PMID: 38704202.","journal-title":"J Gastrointest Surg"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00360-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00360-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00360-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:01:49Z","timestamp":1780873309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43046-026-00360-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00360-z","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This article is a review of published literature and does not involve any new studies with human participants or animals performed by any author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form (e.g., personal details, images, or videos).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}